Source:http://linkedlifedata.com/resource/pubmed/id/18641459
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2008-7-25
|
pubmed:abstractText |
Malignant myeloblasts arising in high-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are characterized by the constitutive activation of the anti-apoptotic transcription factor NFkappaB. We found that DNA methyltransferase (DNMT) inhibitors (such as azacytidine and 5-aza-2'-deoxycytidine) and histone deacetylase (HDAC) inhibitors (such as trichostatin and valproic acid) efficiently induced apoptosis in the P39 MDS/AML cell line, correlating with an inhibition of NFkappaB (which translocated from the nucleus to the cytoplasm). This effect was obtained rapidly, within a few hours, suggesting that it was not due to epigenetic reprogramming. Indeed, DNMT and HDAC inhibitors reduced the phosphorylation of the NFkappaB-activating kinase IKKalpha/beta, and this effect was also observed in enucleated cells. Finally, circulating myeloblasts from AML patients treated with the DNMT inhibitor 5-aza-2'-deoxycytidine manifested a rapid (2 hours post-treatment) inhibition of NFkappaB and IKKalpha/beta. Altogether, these results indicate that DNMT and HDAC inhibitors can inhibit the constitutive activation of NFkappaB in malignant myeloblasts in vitro and in vivo through a novel mechanism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Azacitidine,
http://linkedlifedata.com/resource/pubmed/chemical/DNA (Cytosine-5-)-Methyltransferase,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Histone Deacetylase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxamic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/I-kappa B Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Valproic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/trichostatin A
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1551-4005
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2139-45
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18641459-Azacitidine,
pubmed-meshheading:18641459-Cell Line, Tumor,
pubmed-meshheading:18641459-DNA (Cytosine-5-)-Methyltransferase,
pubmed-meshheading:18641459-Enzyme Inhibitors,
pubmed-meshheading:18641459-Female,
pubmed-meshheading:18641459-Granulocyte Precursor Cells,
pubmed-meshheading:18641459-Histone Deacetylase Inhibitors,
pubmed-meshheading:18641459-Humans,
pubmed-meshheading:18641459-Hydroxamic Acids,
pubmed-meshheading:18641459-I-kappa B Kinase,
pubmed-meshheading:18641459-Leukemia, Myeloid, Acute,
pubmed-meshheading:18641459-Male,
pubmed-meshheading:18641459-Middle Aged,
pubmed-meshheading:18641459-NF-kappa B,
pubmed-meshheading:18641459-Valproic Acid
|
pubmed:year |
2008
|
pubmed:articleTitle |
A novel effect of DNA methyltransferase and histone deacetylase inhibitors: NFkappaB inhibition in malignant myeloblasts.
|
pubmed:affiliation |
INSERM, U848, Unit Apoptosis, Cancer and Immunity, Villejuif, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|